BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33611093)

  • 21. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.
    Tubman VN; Levine JE; Campagna DR; Monahan-Earley R; Dvorak AM; Neufeld EJ; Fleming MD
    Blood; 2007 Apr; 109(8):3297-9. PubMed ID: 17209061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.
    Laricchia-Robbio L; Fazzina R; Li D; Rinaldi CR; Sinha KK; Chakraborty S; Nucifora G
    Mol Cell Biol; 2006 Oct; 26(20):7658-66. PubMed ID: 16954386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.
    Gilles L; Arslan AD; Marinaccio C; Wen QJ; Arya P; McNulty M; Yang Q; Zhao JC; Konstantinoff K; Lasho T; Pardanani A; Stein B; Plo I; Sundaravel S; Wickrema A; Migliaccio A; Gurbuxani S; Vainchenker W; Platanias LC; Tefferi A; Crispino JD
    J Clin Invest; 2017 Apr; 127(4):1316-1320. PubMed ID: 28240607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and genetic heterogeneity arising from a novel substitution at amino acid position Val205 in GATA1 related X-linked thrombocytopenia with dyserythropoietic anemia.
    Jamwal M; Aggarwal A; Sharma P; Bansal D; Maitra A; Das R
    Blood Cells Mol Dis; 2020 Mar; 81():102391. PubMed ID: 31865264
    [No Abstract]   [Full Text] [Related]  

  • 25. Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia.
    Zaninetti C; Rivera J; Vater L; Ohlenforst S; Leinøe E; Böckelmann D; Freson K; Thiele T; Makhloufi H; Rath M; Eberl W; Wolff M; Freyer C; Wesche J; Zieger B; Felbor U; Heidel FH; Greinacher A
    J Thromb Haemost; 2024 Apr; 22(4):1179-1186. PubMed ID: 38103735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-linked thrombocytopenia caused by a novel mutation of GATA-1.
    Mehaffey MG; Newton AL; Gandhi MJ; Crossley M; Drachman JG
    Blood; 2001 Nov; 98(9):2681-8. PubMed ID: 11675338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.
    Hofmann I; Geer MJ; Vögtle T; Crispin A; Campagna DR; Barr A; Calicchio ML; Heising S; van Geffen JP; Kuijpers MJE; Heemskerk JWM; Eble JA; Schmitz-Abe K; Obeng EA; Douglas M; Freson K; Pondarré C; Favier R; Jarvis GE; Markianos K; Turro E; Ouwehand WH; Mazharian A; Fleming MD; Senis YA
    Blood; 2018 Sep; 132(13):1399-1412. PubMed ID: 29898956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms.
    Yang N; Park S; Cho MS; Lee M; Hong KS; Mun YC; Seong CM; Huh HJ; Huh J
    Ann Lab Med; 2018 Jul; 38(4):296-305. PubMed ID: 29611379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GATA1 downregulation in prefibrotic and fibrotic stages of primary myelofibrosis and in the myelofibrotic progression of other myeloproliferative neoplasms.
    Sangiorgio VFI; Nam A; Chen Z; Orazi A; Tam W
    Leuk Res; 2021 Jan; 100():106495. PubMed ID: 33360878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe gastrointestinal bleeding and thrombocytopenia in a child with an anti-GATA1 autoantibody.
    de Waele L; Freson K; Louwette S; Thys C; Wittevrongel C; de Vos R; Debeer A; van Geet C
    Pediatr Res; 2010 Mar; 67(3):314-9. PubMed ID: 19924028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GATA1 mutations in red cell disorders.
    Ling T; Crispino JD
    IUBMB Life; 2020 Jan; 72(1):106-118. PubMed ID: 31652397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perturbed MafB/GATA1 axis after burn trauma bares the potential mechanism for immune suppression and anemia of critical illness.
    Johnson NB; Posluszny JA; He LK; Szilagyi A; Gamelli RL; Shankar R; Muthumalaiappan K
    J Leukoc Biol; 2016 Oct; 100(4):725-736. PubMed ID: 26992433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
    Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
    Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel GATA1 mutation (Stop414Arg) in a family with the rare X-linked blood group Lu(a-b-) phenotype and mild macrothrombocytic thrombocytopenia.
    Singleton BK; Roxby DJ; Stirling JW; Spring FA; Wilson C; Poole J; Anstee DJ
    Br J Haematol; 2013 Apr; 161(1):139-42. PubMed ID: 23278136
    [No Abstract]   [Full Text] [Related]  

  • 36. The thrombopoietin/MPL axis is activated in the Gata1
    Zingariello M; Sancillo L; Martelli F; Ciaffoni F; Marra M; Varricchio L; Rana RA; Zhao C; Crispino JD; Migliaccio AR
    Blood Cancer J; 2017 Jun; 7(6):e572. PubMed ID: 28622305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel G6B gene variant causes familial autosomal recessive thrombocytopenia and anemia.
    Melhem M; Abu-Farha M; Antony D; Madhoun AA; Bacchelli C; Alkayal F; AlKhairi I; John S; Alomari M; Beales PL; Alsmadi O
    Eur J Haematol; 2017 Mar; 98(3):218-227. PubMed ID: 27743390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.
    Zhang MY; Churpek JE; Keel SB; Walsh T; Lee MK; Loeb KR; Gulsuner S; Pritchard CC; Sanchez-Bonilla M; Delrow JJ; Basom RS; Forouhar M; Gyurkocza B; Schwartz BS; Neistadt B; Marquez R; Mariani CJ; Coats SA; Hofmann I; Lindsley RC; Williams DA; Abkowitz JL; Horwitz MS; King MC; Godley LA; Shimamura A
    Nat Genet; 2015 Feb; 47(2):180-5. PubMed ID: 25581430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lenalidomide therapy in myelofibrosis with myeloid metaplasia.
    Tefferi A; Cortes J; Verstovsek S; Mesa RA; Thomas D; Lasho TL; Hogan WJ; Litzow MR; Allred JB; Jones D; Byrne C; Zeldis JB; Ketterling RP; McClure RF; Giles F; Kantarjian HM
    Blood; 2006 Aug; 108(4):1158-64. PubMed ID: 16609064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GATA factor mutations in hematologic disease.
    Crispino JD; Horwitz MS
    Blood; 2017 Apr; 129(15):2103-2110. PubMed ID: 28179280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.